1st Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Firm
Client
Income
—
Expenses
$980,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
CHRIS FRECH —
JILL HAMAKER —
ALLEN SHOFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
CHRIS FRECH —
JILL HAMAKER —
ALLEN SHOFE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

LobbyistCovered position, as disclosed
CHRIS FRECH —
JILL HAMAKER —
ALLEN SHOFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.